Special: Over $2,500 Profit in the First Month



CDNA: CareDx, Inc. is a Sell

The current rating for CDNA is 50, which is 0% below its historic median rating of 50. This indicates lower risk than normal.

The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.